Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
4.540
+0.160 (3.65%)
Jun 18, 2026, 4:00 PM EDT - Market closed

Myriad Genetics Stock Forecast

Stock Price Forecast

According to 9 analysts polled by S&P Global, Myriad Genetics stock has a consensus rating of "Hold" and an average price target of $6.25. The average 1-year stock price forecast is 37.67% higher than the current stock price, while the lowest is $4.00 (-11.89%) and the highest is $10 (+120.26%).

Price Target: $6.25 (+37.67%)
Analyst Consensus: Hold
TargetLowAverageMedianHigh
Price$4.00$6.25$5.75$10
Change-11.89%+37.67%+26.65%+120.26%
* Price targets were last updated on May 12, 2026.

Analyst Ratings

The average analyst rating for Myriad Genetics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy111111
Buy222111
Hold777765
Sell111111
Strong Sell111111
Total12121211109

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Piper Sandler
Piper Sandler
Buy
Maintains
$8.5
BuyMaintains$8.5+87.22%May 12, 2026
Bank of America Securities
Bank of America Securities
Sell
Maintains
n/a
SellMaintainsn/an/aMay 7, 2026
Unknown Analyst
Guggenheim
No rating
Guggenheim
Hold
Maintains
n/a
HoldMaintainsn/an/aMay 7, 2026
Wells Fargo
Wells Fargo
Hold
Maintains
$6$5.5
HoldMaintains$6$5.5+21.15%May 6, 2026
Craig-Hallum
Craig-Hallum
Buy
Reiterates
$10
BuyReiterates$10+120.26%May 6, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
863.56M
from 824.50M
Increased by 4.74%
Revenue Next Year
915.82M
from 863.56M
Increased by 6.05%
EPS This Year
0.05
from 0.06
Decreased by -20.37%
EPS Next Year
0.15
from 0.05
Increased by 216.26%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
690.60M678.40M753.20M837.60M824.50M863.56M
Revenue Growth
23.99%-1.77%11.03%11.21%-1.56%4.74%
Gross Profit
493.00M476.40M517.00M585.40M576.60M593.61M
Gross Margin
71.39%70.22%68.64%69.89%69.93%68.74%
Operating Income
-126.70M-123.70M-144.60M-88.00M-67.80M11.48M
Net Income
-27.20M-112.00M-263.30M-127.30M-365.90M-71.48M
EPS
----0.060.05
EPS Growth
-----57.14%-20.37%
Forward PE
---141.34196.4995.02
Free Cash Flow
149.49M-115.71M-59.29M13.25M762.50K-16.50M
No. Analysts
-----9
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High870.5M
Avg863.6M
Low859.2M

Revenue Growth

Revenue Growth202620272028
High
5.6%
Avg
4.7%
Low
4.2%

EPS Forecast

EPS202620272028
High0.09
Avg0.05
Low-0.06

EPS Growth

EPS Growth202620272028
High
50.0%
Avg
-20.4%
Low-